The acute phase of experimental Chagas' disease in the mouse, after infection with the Brazil strain of Trypanosoma cruzi, can be divided into two periods (13) . In the early acute phase, there occurs a non-antibody-mediated control of parasite proliferation. In the late acute phase, the production of antibody to the parasite becomes increasingly important for the clearance of parasites from the blood. The mechanism involved in the early control of parasite proliferation has not yet been identified, but it appears to be present in all strains of mice regardless of their resistance or susceptibility to T. cruzi. The initial exceptions were nulnu mice which displayed an early rapid rise in parasitemia after challenge (14) . The lack of the early control mechanism in these mice suggested that its functioning may be immunologically mediated and dependent upon the presence of a thymus.
More recently, the BXH-2 recombinant inbred strain was reported to have a course of parasitemia similar to that seen in nulnu mice after challenge with the highly virulent Peru strain of T. cruzi (15) . The early control of parasite proliferation was also absent when infection was initiated with the less virulent Brazil strain of T. cruzi (13) . Unlike nulnu mice, BXH-2 mice have no known immunological defect and mount a normal antibody response to the parasite (13) .
Many immune mechanisms have been demonstrated in vitro to be capable of killing T. cruzi. The importance of antibody in the chronic phase for the maintenance of immunity and for the clearance of parasites from the blood has been suggested in several studies (9, 10, 13) . Immune mechanisms, either specific or nonspecific, active in vivo early in the acute phase in the killing of T. cruzi or in the limiting of its growth have not been as easily identifiable.
Since the BXH-2 strain may lack or have a diminished activity in a particular function of the host defense system of importance for the early control of parasite proliferation, the study of the defect present in this strain is of especial interest.
The BXH recombinant inbred series of strains was derived from the C3H/HeJ and C57BL/6J strains (12) . A trait which is not present in either parental strain but which is found in the BXH-2 strain could be the result of a particular combination of genes from the parental strains or of a mutation which arose during the inbreeding of the strain and became fixed in it. The present paper presents evidence in support of the latter hypothesis.
MATERIALS AND METHODS
Parasites. The Brazil strain of T. cruzi was used in all experiments and was maintained by passage in C3H/HeJ mice. For challenge of animals, blood was drawn from the retro-orbital complex of an infected C3H mouse into a heparinized pipette. The degree of parasitemia was determined, and the blood was diluted with Dulbecco modified Eagle medium to the desired concentration. Mice were infected intraperitoneally with 0.5 ml of the diluted blood.
Animals. C3H/HeJ, C57BL/6J, C57BL16-lprllpr, and BXH-2 recombinant inbred mice were purchased from The Jackson Laboratory, Bar Harbor, Maine. All crosses were carried out in our animal facility. In matings involving BXH-2 mice, the BXH-2 mouse was usually the male.
Determination of blood parasitemias. To determine parasi- 
RESULTS
The defect in the BXH-2 strain could have arisen from a mutation introduced in the inbreeding of the strain or from a particular combination of genes derived from its parental strains. In the former case, the control of parasite proliferation would be due to a single gene differing in the BXH-2 strain and the parental strains. In the latter case, at least two genes would be involved in the lack of control of proliferation in the BXH-2 strain, with at least a single gene differing between the BXH-2 strain and each of the parental strains.
Crosses were carried out between the BXH-2 strain and each of the parental strains. Progeny were challenged, and their parasitemias measured 16 C57BL/6 strain and to F1 mice. Not all mice lacking the early control mechanism achieved levels of parasitemia as high as those seen in BXH-2 mice. However, in all groups, there was little difficulty in separating mice which had or lacked the early control mechanism. As expected, the higher susceptibility of male mice (7) resulted in slightly higher levels of parasitemia than seen in female mice.
The number of mice from each cross showing early control of parasite proliferation is summarized in Table 1 . The ability to limit early proliferation is a dominant trait as shown by its presence in all F1 mice. The distribution of the trait among F2 and backcross mice is consistent with a single locus difference between the BXH-2 strain and each of the parental strains.
These results did not indicate whether the same gene locus was implicated in the C3H and the C57BL/6 strains. The defect of the BXH-2 mice could be the result of the combined presence of two gene loci differing in the C3H and C57BL/6 strains. If the two identified loci did differ between the progenitor strains and were unlinked, then 1/16 of all F2 mice derived from these parental strains should be homozygous for the two recessive alleles. None of the F2 mice tested showed the inability to control early parasite proliferation (Table 2 ). Similarly, if two different genes had been identified, then one-fourth of the progeny from a cross between (C57BL/6 x C3H)Fj mice and BXH-2 mice should show the lack of early control. Of 260 mice tested, all had low levels of parasitemia on day 16 postinfection. The results are therefore not consistent with the defect in the BXH-2 strain arising from a combination of genes from the C3H and the C57BL/6 strains.
Several inbred strains of mice carrying the mutant gene lpr have been shown to develop parasitemias during the acute disease 2 to 10 times higher than those in their congenic partners (2) . When C57BL/6J-lprllpr mice were challenged with the Brazil strain of T. cruzi, only low levels of parasitemia were observed through the first 3 weeks postinfection (Table 3) . By 4 to 5 weeks postinfection high levels of parasitemia did develop in some mice. When C57BLI6J-lpr/ lpr mice were crossed with BXH-2 mice, the F1 progeny all displayed an early control of parasite proliferation. The genetic defect in the BXH-2 strain does not appear to be related to the Ipr mutation. activity in a particular function of the host defense system which results in an inability to control early proliferation of the parasite T. cruzi. Our genetic analysis of the defect present in the BXH-2 strain suggests that this trait arose as a result of a mutation at one locus rather than as a result of a particular combination of genes derived from its parental strains, C3H/HeJ and C57BL/6J.
The choice of the level of parasitemia 16 days after infection as the criterion for the presence of the early control mechanism was based on the observation that the early rapid rise in parasitemia in BXH-2 mice abates about day 18 postinfection (13). This occurs as the level of antibody to the parasite is rapidly increasing. The level of parasitemia on day 16 is likely to be due primarily to the efficacy of the early non-antibody-mediated control mechanism rather than to the antibody-dependent mechanisms that function later in the clearance of parasites from the blood (13) .
In mice lacking the early control mechanism, the parasitemias measured on day 16 postinfection varied over a wide range ( Fig. 1 and 2 ). Our experience with the Brazil strain of T. cruzi has been that even within groups of mice challenged at the same time, once the level of parasitemia reaches several million parasites per milliliter, the parasitemias in some mice will markedly increase whereas other mice will show little if any further increase. Among the progeny from the various crosses made, the level of parasitemia on day 16 postinfection could also vary due to the influence of other genes, although this would not explain the variation seen among the inbred BXH-2 mice. Despite the range of parasitemias seen in mice unable to limit early parasite proliferation, there was no difficulty in classifying F2 or backcross mice as having or lacking the early control trait.
The genetic studies demonstrate a single locus difference between the BXH-2 strain and each of its parental strains, with the ability to limit early proliferation being the dominant trait. The loci in the C3H and C57BL/6 strains appear to be identical since all F2 mice derived from C3H and C57BL/6 parents displayed the early control trait. In addition, the early control of proliferation was present in all progeny from a cross between BXH-2 and (C57BL/6 x C3H)Fj mice. A mutation is thus likely to have occurred in the derivation of the BXH-2 strain. Of course, the possibility remains that the loci in the parental strains are different but are very closely linked. The defect in the BXH-2 strain would then be the result of a rare recombination which became fixed in the inbreeding of the BXH-2 strain.
The provisional designation Crz has been given to the locus in the BXH-2 strain that is responsible for the inability (100) a Presence of the early control of parasites proliferation was determined by the level of parasitemia 16 days after infection.
b Does not differ significantly from the expected frequency of 75% for a single gene controlling early parasite proliferation; P > 0.05.
C Does not differ significantly from the expected frequency of 50% for a single gene controlling early parasite proliferation; P > 0.05.
to control early proliferation of T. cruzi. A more specific designation awaits identification of the function of this locus.
Higher than normal parasitemias in the acute phase have also been reported to occur in a variety of autoimmune strains of mice (2) . In particular, mice bearing the single autosomal recessive gene lpr are highly susceptible to acute infections with the Y strain of T. cruzi. However, C57BL/6J-lprllpr mice infected with the Brazil strain of T. cruzi did not show an early rapid rise in parasitemia, although most of the infected mice did eventually develop high parasitemias and die. The variation in results is most likely associated with differences in the strains of T. cruzi used. F1 mice derived from a cross between BXH-2 and C57BL/6J-lpr/lpr mice were also able to effect the early control of proliferation of T. cruzi. The lpr gene and the Crz locus appear to be distinct.
The unusual susceptibility of the BXH-2 strain to infection with T. cruzi is not unique to this organism. Innate resistance of inbred mice to infection with Mycobacterium bovis is regulated by a single, dominant, autosomal gene designated Bcg which exists in two allelic forms: resistant (Bcgr) and susceptible (Bcgs) (6) . The BXH-2 strain carries the Bcgr allele but is phenotypically susceptible to infection with M. There is no known immunological defect present in the BXH-2 strain, but mice do spontaneously express a B-tropic murine leukemia virus and do have a high incidence of lymphoma (1) . Neither of these traits is present in the parental C3H/HeJ or C57BL/6J strain nor in any of the other BXH recombinant inbred strains. The cause of these characteristics has not been established.
The genetic basis of murine resistance or susceptibility to infectious agents has now been studied for a wide variety of organisms. Resistance to some organisms, including Salmonella typhimurium, Listeria monocytogenes, L. donovani, and M. bovis, has been found to be related to a slower initial rate of proliferation of the organism than that which occurs in susceptible strains (3, 5, 6, 8) . In studies of the genetic control of responses to T. cruzi, Wrightsman et al. (15) were able to divide inbred strains of mice into two groups based on the level of parasitemia which developed after infection with the highly virulent Peru strain of T. cruzi. The low parasitemia response was found to be inherited in a dominant manner. An early control of parasite proliferation may also be a major determinant of host resistance to T. cruzi. Since the Crz mutation is not found in normal strains of mice susceptible to T. cruzi, the presence of this mutation is not itself the determinant of host resistance. However, the defense mechanism affected by the Crz mutation is of primary importance for the early control of proliferation of T. cruzi, and the effectiveness of this mechanism in different strains of mice may strongly influence host resistance. 
